Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 2,020.00
+20.00 (1.00%)
Apr 28, 2026, 12:44 PM IDT
TLV:TKUN Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 9.1 | 34.95 | 44.23 | 49.3 | 37.03 | Upgrade
|
| Revenue Growth (YoY) | -73.96% | -20.97% | -10.28% | 33.13% | 70.97% | Upgrade
|
| Cost of Revenue | 7.35 | 29.53 | 32.7 | 31.19 | 29.38 | Upgrade
|
| Gross Profit | 1.75 | 5.43 | 11.53 | 18.11 | 7.65 | Upgrade
|
| Selling, General & Admin | 10.47 | 12.62 | 22.82 | 23.95 | 27.66 | Upgrade
|
| Research & Development | - | 0.83 | 3.89 | 5.16 | 7.2 | Upgrade
|
| Other Operating Expenses | 5.15 | -0.12 | -0.64 | -0.33 | 0.85 | Upgrade
|
| Operating Expenses | 16.49 | 19.98 | 39.36 | 44.45 | 50.7 | Upgrade
|
| Operating Income | -14.74 | -14.55 | -27.83 | -26.34 | -43.05 | Upgrade
|
| Interest Expense | -1.09 | -1.88 | -2.3 | -1.77 | -1.28 | Upgrade
|
| Interest & Investment Income | - | - | 0.13 | 0.09 | 0.01 | Upgrade
|
| Earnings From Equity Investments | - | - | -0.38 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -15.82 | -16.44 | -30.38 | -28.02 | -44.32 | Upgrade
|
| Impairment of Goodwill | - | -22.34 | -59.63 | -17.57 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -4.73 | -0.43 | 1.93 | - | Upgrade
|
| Asset Writedown | - | - | - | -15.27 | - | Upgrade
|
| Other Unusual Items | - | 3.4 | -3.56 | 9.79 | 10.29 | Upgrade
|
| Pretax Income | -15.82 | -40.1 | -93.99 | -49.14 | -34.03 | Upgrade
|
| Income Tax Expense | - | - | 0.03 | 0.01 | - | Upgrade
|
| Earnings From Continuing Operations | -15.82 | -40.1 | -94.02 | -49.15 | -34.03 | Upgrade
|
| Minority Interest in Earnings | -0.03 | 0 | 5.13 | 0.91 | 1.38 | Upgrade
|
| Net Income | -15.85 | -40.1 | -88.89 | -48.24 | -32.65 | Upgrade
|
| Net Income to Common | -15.85 | -40.1 | -88.89 | -48.24 | -32.65 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 1.80% | 32.86% | 29.54% | 15.79% | 23.01% | Upgrade
|
| EPS (Basic) | -18.60 | -47.90 | -141.05 | -99.16 | -77.72 | Upgrade
|
| EPS (Diluted) | -18.60 | -47.90 | -141.05 | -99.16 | -77.72 | Upgrade
|
| Free Cash Flow | 2.01 | -3.78 | -4.12 | -23.2 | -33.49 | Upgrade
|
| Free Cash Flow Per Share | 2.36 | -4.52 | -6.54 | -47.70 | -79.70 | Upgrade
|
| Gross Margin | 19.25% | 15.52% | 26.06% | 36.73% | 20.66% | Upgrade
|
| Operating Margin | -161.89% | -41.63% | -62.93% | -53.44% | -116.25% | Upgrade
|
| Profit Margin | -174.17% | -114.73% | -200.97% | -97.85% | -88.17% | Upgrade
|
| Free Cash Flow Margin | 22.08% | -10.82% | -9.31% | -47.07% | -90.43% | Upgrade
|
| EBITDA | -2.25 | 14.22 | 27.56 | 9.2 | -25.89 | Upgrade
|
| EBITDA Margin | -24.73% | 40.69% | 62.32% | 18.66% | -69.92% | Upgrade
|
| D&A For EBITDA | 12.48 | 28.77 | 55.39 | 35.54 | 17.15 | Upgrade
|
| EBIT | -14.74 | -14.55 | -27.83 | -26.34 | -43.05 | Upgrade
|
| EBIT Margin | -161.89% | -41.63% | -62.93% | -53.44% | -116.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.